Daratumumab is a safe and effective rescue therapy for multiple myeloma patients who relapse after allo-HSCT

Bone Marrow Transplant. 2020 Feb;55(2):461-463. doi: 10.1038/s41409-019-0525-1. Epub 2019 Apr 15.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Multiple Myeloma* / drug therapy
  • Neoplasm Recurrence, Local

Substances

  • Antibodies, Monoclonal
  • daratumumab